 |
 |
 |
|
Lack of Pharmacokinetic Drug-Drug Interaction Between
Norgestimate/Ethinyl Estradiol and Sofosbuvir/Velpatasvir/Voxilaprevir
|
|
|
Reported by Jules Levin
18th International Workshop on Clinical Pharmacology of Antiviral Therapy, June 14-16, 2017, Chicago, IL
Kimberly L. Garrison, Grace Ma, Luisa M. Stamm, John Ling, Anita Mathias
Gilead Sciences, Inc., Foster City, CA








1. Bourliere M, et al. AASLD 2016, abstr 194;
2. Foster G, et al. AASLD 2016, abstr 258;
3. Jacobsen I, et al. AASLD
2016, abstr LB-12;
4. Zeuzem S, et al. AASLD 2016, abstr 109;
5. ORTHO TRI-CYCLEN® Lo [package insert].
Titusville, NJ: Janssen Pharmaceuticals, Inc., Aug 2012;
6. German P, et al. J Clin Pharmacol 2014;54:1290-8;
7. Mogalian E, et al. AASLD 2014, abstr 1998;
8. Kirby B, et al. IWCPHHT 2016, abstr O_24;
9. Kirby B, et al. IWCPHHT
2016, abstr O_25;
10. Barditch-Crovo P, et al. Clin Pharmacol Ther 1999;65:428-38;
11. FSH and LH Reference
Ranges. Quest Diagnostics, 2013. http://www.questdiagnostics.com/testcenter/BUOrderInfo.action?tc=7137&lab-
Code=SEA;
12. Progesterone, LC/MS/MS Reference Ranges. Quest Diagnostics 2013.
http://www.questdiagnostics.com/testcenter/TestDetail.action?ntc=17183;
|
|
|
 |
 |
|
|